SS-31 (Elamipretide) Research Overview

SS-31 is a synthetic tetrapeptide belonging to a class known as Szeto-Schiller (SS) peptides, designed to accumulate in mitochondria. In pharmaceutical development it is known as elamipretide, also designated MTP-131 and Bendavia in earlier literature.

Its defining research characteristic is selective association with the inner mitochondrial membrane, which distinguishes it from compounds that act at the cell surface or in the cytosol.

The SS peptide class was developed in academic work aimed at creating molecules that concentrate within mitochondria independently of membrane potential, a property that differentiates them from earlier lipophilic cation approaches.

SS-31 was subsequently advanced into pharmaceutical development as elamipretide and studied in registered clinical trials, making it unusual among compounds commonly found in research-supply catalogs.

The central proposed mechanism involves cardiolipin, a phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin is required for the proper organization of the electron transport chain and for the shape of cristae, the folds of the inner membrane where oxidative phosphorylation occurs.

Researchers have reported that SS-31 associates with cardiolipin and may influence its interactions with respiratory chain components, with downstream effects on cristae structure and electron transport efficiency measured in isolated mitochondria and cell systems.

Related work has examined reactive oxygen species production, ATP synthesis rates, and mitochondrial membrane integrity as bioenergetic readouts.

Mitochondrial membrane biology — cardiolipin interaction and cristae architecture.

Bioenergetics — oxygen consumption, ATP production, and electron transport chain function.

Oxidative stress research in isolated mitochondria and cell models.

Cardiac research, including heart failure models and clinical investigation.

Primary mitochondrial disease research, including registered clinical trials in mitochondrial myopathy.

Ophthalmic research in registered trials for specific retinal conditions.

Mechanistic evidence comes from biophysical studies, isolated mitochondria, cell culture, and animal models, and is comparatively well developed for a compound of this class.

Unlike most compounds in this library, elamipretide has been evaluated in registered human clinical trials, including programs in primary mitochondrial myopathy, heart failure with reduced ejection fraction, and certain ophthalmic conditions.

Trial results have been mixed. Several studies did not meet their primary endpoints, while some reported effects on secondary or subgroup measures. Mixed and partly negative trial outcomes are an accurate description of the current record, and elamipretide has not been established as an approved therapy on the basis of that record. Registered trial information can be reviewed directly on ClinicalTrials.gov.

Clinical trial results to date have been inconsistent across indications and endpoints.

Endpoint selection in mitochondrial disease research is difficult, since functional measures may not capture the biology being targeted.

Patient populations in mitochondrial disease trials are small and heterogeneous.

The precise molecular consequences of cardiolipin association remain an area of ongoing biophysical study.

SS-31 / elamipretide is a mitochondria-targeting tetrapeptide whose research centers on cardiolipin, cristae structure, and bioenergetics.

It has a more developed mechanistic literature than most compounds in this library and has been studied in registered human clinical trials.

Clinical results have been mixed, and its investigational status should not be described as established clinical efficacy.

This page is provided for scientific and educational purposes only. It summarizes published laboratory research and does not constitute medical advice, does not describe any approved therapy, and does not provide instructions for human use of any kind.

SFVLAB supplies this compound strictly as a research-use-only material for laboratory investigation.